Alcista
$9.49
Precio del escenario
$9.730
-0.069 (-0.71%)Al cierre
Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services.
Viemed Healthcare Inc is a good buy right now due to its current price of $9.80, which is significantly below the analyst price target of $14. The company has shown strong revenue growth, with Q2 revenue of $78.1 million, a 23.7% increase year-over-year, and a gross margin of 57.7%. However, the main risk is the earnings miss in the last report, where EPS was $0.07 compared to the expected $0.10, indicating potential profitability pressures.
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Viemed to Host Q3 2026 Earnings Call on November 5

Viemed Healthcare Reports Record Q2 Earnings Amid Ventilation Growth

Viemed Healthcare Q2 Financial Highlights

Viemed Healthcare Reports Earnings Miss

Viemed to Host Q2 2026 Earnings Call on August 4
Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services. It operates in the Healthcare sector (SERVICES-MISC HEALTH & ALLIED SERVICES, NEC industry).
Viemed Healthcare Inc is a good buy right now due to its current price of $9.80, which is significantly below the analyst price target of $14. The company has shown strong revenue growth, with Q2 revenue of $78.1 million, a 23.7% increase year-over-year, and a gross margin of 57.7%. However, the main risk is the earnings miss in the last report, where EPS was $0.07 compared to the expected $0.10, indicating potential profitability pressures.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.